Glucose-conjugated MGMT inhibitor

Alternative_Names

O6BTG-C8-βGlu
CAS

382607-78-5
MWt

616.53
Formula

C24H34BrN5O7S
Solubility

10 mM in DMSO
Clinical_Information

No Development Reported
Pathway

Epigenetics
Target

DNA Methyltransferase
Datasheet
SDS
Description

Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.

Gene target

Glucose-conjugated MGMT inhibitor
Gene symbol

MGMT
Short name

Glucose-conjugated MGMT inhibitor
Technique

antibody Conjugates
Alternative name

Glucose-coupled O-6-methylguanine-Desoxyribonucleic acid methyltransferase suppressor
Alternative to gene target

O-6-methylguanine-DNA methyltransferase, MGMT and IDBG-93188 and ENSG00000170430 and 4255, DNA-methyltransferase activity, nuclei, Mgmt and IDBG-211408 and ENSMUSG00000054612 and 17314